A PHP Error was encountered

Severity: Warning

Message: fopen(/var/cpanel/php/sessions/ea-php72/ci_session3a415463f5b7996d1d69fc23ecd47e87053dfb90): failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 176

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /var/cpanel/php/sessions/ea-php72)

Filename: Session/Session.php

Line Number: 143

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

Global Short Bowel Syndrome (SBS) Market Research Report 2024

img

Global Short Bowel Syndrome (SBS) Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Short Bowel Syndrome (SBS) Market Research Report 2024

Short bowel syndrome (SBS) is a metabolic disorder occurs when the portion of the small intestine is not functioning or removed through surgery due to digestive illness. SBS is caused by lack of function of the small intestine. This results in malabsorption, diarrhea, steatorrhea, fluid and electrolyte disturbances, and malnutrition.
According to MRAResearch’s new survey, global Short Bowel Syndrome (SBS) market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Short Bowel Syndrome (SBS) market research.
During 2017, the parental route segment accounted for the major shares and dominated the SBS market. Factors such as the rapid action mechanism of the drug and the prolonged action result contribute to the growth of this market segment in the coming years. In the parental route, the drug is administered intravenously, subcutaneously, intrathecally, or through intramuscular routes and is applied when the oral route of drug administration is ineffective.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Short Bowel Syndrome (SBS) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Merck
Takeda
Emmaus Medical
Ardelyx
Naia Pharmaceuticals
Nutrinia
OxThera
Sancilio Pharmaceuticals
Zealand Pharma
Segment by Type
Oral Route
Parental Route
Segment by Sale Channel
Hospitals
Clinics
Retail Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Short Bowel Syndrome (SBS) report covers below items
Chapter 1Product Basic Information (Definition, Type and Sale Channel)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Sale Channel Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Short Bowel Syndrome (SBS) Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Oral Route
1.2.3 Parental Route
1.3 Market by Sale Channel
1.3.1 Global Short Bowel Syndrome (SBS) Market Growth by Sale Channel: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Short Bowel Syndrome (SBS) Market Perspective (2018-2033)
2.2 Short Bowel Syndrome (SBS) Growth Trends by Region
2.2.1 Global Short Bowel Syndrome (SBS) Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Short Bowel Syndrome (SBS) Historic Market Size by Region (2018-2023)
2.2.3 Short Bowel Syndrome (SBS) Forecasted Market Size by Region (2024-2033)
2.3 Short Bowel Syndrome (SBS) Market Dynamics
2.3.1 Short Bowel Syndrome (SBS) Industry Trends
2.3.2 Short Bowel Syndrome (SBS) Market Drivers
2.3.3 Short Bowel Syndrome (SBS) Market Challenges
2.3.4 Short Bowel Syndrome (SBS) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Short Bowel Syndrome (SBS) Players by Revenue
3.1.1 Global Top Short Bowel Syndrome (SBS) Players by Revenue (2018-2023)
3.1.2 Global Short Bowel Syndrome (SBS) Revenue Market Share by Players (2018-2023)
3.2 Global Short Bowel Syndrome (SBS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Short Bowel Syndrome (SBS) Revenue
3.4 Global Short Bowel Syndrome (SBS) Market Concentration Ratio
3.4.1 Global Short Bowel Syndrome (SBS) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Short Bowel Syndrome (SBS) Revenue in 2022
3.5 Short Bowel Syndrome (SBS) Key Players Head office and Area Served
3.6 Key Players Short Bowel Syndrome (SBS) Product Solution and Service
3.7 Date of Enter into Short Bowel Syndrome (SBS) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Short Bowel Syndrome (SBS) Breakdown Data by Type
4.1 Global Short Bowel Syndrome (SBS) Historic Market Size by Type (2018-2023)
4.2 Global Short Bowel Syndrome (SBS) Forecasted Market Size by Type (2024-2033)
5 Short Bowel Syndrome (SBS) Breakdown Data by Sale Channel
5.1 Global Short Bowel Syndrome (SBS) Historic Market Size by Sale Channel (2018-2023)
5.2 Global Short Bowel Syndrome (SBS) Forecasted Market Size by Sale Channel (2024-2033)
6 North America
6.1 North America Short Bowel Syndrome (SBS) Market Size (2018-2033)
6.2 North America Short Bowel Syndrome (SBS) Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Short Bowel Syndrome (SBS) Market Size by Country (2018-2023)
6.4 North America Short Bowel Syndrome (SBS) Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Short Bowel Syndrome (SBS) Market Size (2018-2033)
7.2 Europe Short Bowel Syndrome (SBS) Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Short Bowel Syndrome (SBS) Market Size by Country (2018-2023)
7.4 Europe Short Bowel Syndrome (SBS) Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Short Bowel Syndrome (SBS) Market Size (2018-2033)
8.2 Asia-Pacific Short Bowel Syndrome (SBS) Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Short Bowel Syndrome (SBS) Market Size by Region (2018-2023)
8.4 Asia-Pacific Short Bowel Syndrome (SBS) Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Short Bowel Syndrome (SBS) Market Size (2018-2033)
9.2 Latin America Short Bowel Syndrome (SBS) Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Short Bowel Syndrome (SBS) Market Size by Country (2018-2023)
9.4 Latin America Short Bowel Syndrome (SBS) Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Short Bowel Syndrome (SBS) Market Size (2018-2033)
10.2 Middle East & Africa Short Bowel Syndrome (SBS) Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Short Bowel Syndrome (SBS) Market Size by Country (2018-2023)
10.4 Middle East & Africa Short Bowel Syndrome (SBS) Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Detail
11.1.2 Merck Business Overview
11.1.3 Merck Short Bowel Syndrome (SBS) Introduction
11.1.4 Merck Revenue in Short Bowel Syndrome (SBS) Business (2018-2023)
11.1.5 Merck Recent Development
11.2 Takeda
11.2.1 Takeda Company Detail
11.2.2 Takeda Business Overview
11.2.3 Takeda Short Bowel Syndrome (SBS) Introduction
11.2.4 Takeda Revenue in Short Bowel Syndrome (SBS) Business (2018-2023)
11.2.5 Takeda Recent Development
11.3 Emmaus Medical
11.3.1 Emmaus Medical Company Detail
11.3.2 Emmaus Medical Business Overview
11.3.3 Emmaus Medical Short Bowel Syndrome (SBS) Introduction
11.3.4 Emmaus Medical Revenue in Short Bowel Syndrome (SBS) Business (2018-2023)
11.3.5 Emmaus Medical Recent Development
11.4 Ardelyx
11.4.1 Ardelyx Company Detail
11.4.2 Ardelyx Business Overview
11.4.3 Ardelyx Short Bowel Syndrome (SBS) Introduction
11.4.4 Ardelyx Revenue in Short Bowel Syndrome (SBS) Business (2018-2023)
11.4.5 Ardelyx Recent Development
11.5 Naia Pharmaceuticals
11.5.1 Naia Pharmaceuticals Company Detail
11.5.2 Naia Pharmaceuticals Business Overview
11.5.3 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Introduction
11.5.4 Naia Pharmaceuticals Revenue in Short Bowel Syndrome (SBS) Business (2018-2023)
11.5.5 Naia Pharmaceuticals Recent Development
11.6 Nutrinia
11.6.1 Nutrinia Company Detail
11.6.2 Nutrinia Business Overview
11.6.3 Nutrinia Short Bowel Syndrome (SBS) Introduction
11.6.4 Nutrinia Revenue in Short Bowel Syndrome (SBS) Business (2018-2023)
11.6.5 Nutrinia Recent Development
11.7 OxThera
11.7.1 OxThera Company Detail
11.7.2 OxThera Business Overview
11.7.3 OxThera Short Bowel Syndrome (SBS) Introduction
11.7.4 OxThera Revenue in Short Bowel Syndrome (SBS) Business (2018-2023)
11.7.5 OxThera Recent Development
11.8 Sancilio Pharmaceuticals
11.8.1 Sancilio Pharmaceuticals Company Detail
11.8.2 Sancilio Pharmaceuticals Business Overview
11.8.3 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Introduction
11.8.4 Sancilio Pharmaceuticals Revenue in Short Bowel Syndrome (SBS) Business (2018-2023)
11.8.5 Sancilio Pharmaceuticals Recent Development
11.9 Zealand Pharma
11.9.1 Zealand Pharma Company Detail
11.9.2 Zealand Pharma Business Overview
11.9.3 Zealand Pharma Short Bowel Syndrome (SBS) Introduction
11.9.4 Zealand Pharma Revenue in Short Bowel Syndrome (SBS) Business (2018-2023)
11.9.5 Zealand Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Short Bowel Syndrome (SBS) Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Oral Route
Table 3. Key Players of Parental Route
Table 4. Global Short Bowel Syndrome (SBS) Market Size Growth by Sale Channel (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Short Bowel Syndrome (SBS) Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Short Bowel Syndrome (SBS) Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Short Bowel Syndrome (SBS) Market Share by Region (2018-2023)
Table 8. Global Short Bowel Syndrome (SBS) Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Short Bowel Syndrome (SBS) Market Share by Region (2024-2033)
Table 10. Short Bowel Syndrome (SBS) Market Trends
Table 11. Short Bowel Syndrome (SBS) Market Drivers
Table 12. Short Bowel Syndrome (SBS) Market Challenges
Table 13. Short Bowel Syndrome (SBS) Market Restraints
Table 14. Global Short Bowel Syndrome (SBS) Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Short Bowel Syndrome (SBS) Market Share by Players (2018-2023)
Table 16. Global Top Short Bowel Syndrome (SBS) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Short Bowel Syndrome (SBS) as of 2022)
Table 17. Ranking of Global Top Short Bowel Syndrome (SBS) Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Short Bowel Syndrome (SBS) Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Short Bowel Syndrome (SBS) Product Solution and Service
Table 21. Date of Enter into Short Bowel Syndrome (SBS) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Short Bowel Syndrome (SBS) Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Short Bowel Syndrome (SBS) Revenue Market Share by Type (2018-2023)
Table 25. Global Short Bowel Syndrome (SBS) Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Short Bowel Syndrome (SBS) Revenue Market Share by Type (2024-2033)
Table 27. Global Short Bowel Syndrome (SBS) Market Size by Sale Channel (2018-2023) & (US$ Million)
Table 28. Global Short Bowel Syndrome (SBS) Revenue Market Share by Sale Channel (2018-2023)
Table 29. Global Short Bowel Syndrome (SBS) Forecasted Market Size by Sale Channel (2024-2033) & (US$ Million)
Table 30. Global Short Bowel Syndrome (SBS) Revenue Market Share by Sale Channel (2024-2033)
Table 31. North America Short Bowel Syndrome (SBS) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Short Bowel Syndrome (SBS) Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Short Bowel Syndrome (SBS) Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Short Bowel Syndrome (SBS) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Short Bowel Syndrome (SBS) Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Short Bowel Syndrome (SBS) Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Short Bowel Syndrome (SBS) Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Short Bowel Syndrome (SBS) Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Short Bowel Syndrome (SBS) Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Short Bowel Syndrome (SBS) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Short Bowel Syndrome (SBS) Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Short Bowel Syndrome (SBS) Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Short Bowel Syndrome (SBS) Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Short Bowel Syndrome (SBS) Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Short Bowel Syndrome (SBS) Market Size by Country (2024-2033) & (US$ Million)
Table 46. Merck Company Detail
Table 47. Merck Business Overview
Table 48. Merck Short Bowel Syndrome (SBS) Product
Table 49. Merck Revenue in Short Bowel Syndrome (SBS) Business (2018-2023) & (US$ Million)
Table 50. Merck Recent Development
Table 51. Takeda Company Detail
Table 52. Takeda Business Overview
Table 53. Takeda Short Bowel Syndrome (SBS) Product
Table 54. Takeda Revenue in Short Bowel Syndrome (SBS) Business (2018-2023) & (US$ Million)
Table 55. Takeda Recent Development
Table 56. Emmaus Medical Company Detail
Table 57. Emmaus Medical Business Overview
Table 58. Emmaus Medical Short Bowel Syndrome (SBS) Product
Table 59. Emmaus Medical Revenue in Short Bowel Syndrome (SBS) Business (2018-2023) & (US$ Million)
Table 60. Emmaus Medical Recent Development
Table 61. Ardelyx Company Detail
Table 62. Ardelyx Business Overview
Table 63. Ardelyx Short Bowel Syndrome (SBS) Product
Table 64. Ardelyx Revenue in Short Bowel Syndrome (SBS) Business (2018-2023) & (US$ Million)
Table 65. Ardelyx Recent Development
Table 66. Naia Pharmaceuticals Company Detail
Table 67. Naia Pharmaceuticals Business Overview
Table 68. Naia Pharmaceuticals Short Bowel Syndrome (SBS) Product
Table 69. Naia Pharmaceuticals Revenue in Short Bowel Syndrome (SBS) Business (2018-2023) & (US$ Million)
Table 70. Naia Pharmaceuticals Recent Development
Table 71. Nutrinia Company Detail
Table 72. Nutrinia Business Overview
Table 73. Nutrinia Short Bowel Syndrome (SBS) Product
Table 74. Nutrinia Revenue in Short Bowel Syndrome (SBS) Business (2018-2023) & (US$ Million)
Table 75. Nutrinia Recent Development
Table 76. OxThera Company Detail
Table 77. OxThera Business Overview
Table 78. OxThera Short Bowel Syndrome (SBS) Product
Table 79. OxThera Revenue in Short Bowel Syndrome (SBS) Business (2018-2023) & (US$ Million)
Table 80. OxThera Recent Development
Table 81. Sancilio Pharmaceuticals Company Detail
Table 82. Sancilio Pharmaceuticals Business Overview
Table 83. Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Product
Table 84. Sancilio Pharmaceuticals Revenue in Short Bowel Syndrome (SBS) Business (2018-2023) & (US$ Million)
Table 85. Sancilio Pharmaceuticals Recent Development
Table 86. Zealand Pharma Company Detail
Table 87. Zealand Pharma Business Overview
Table 88. Zealand Pharma Short Bowel Syndrome (SBS) Product
Table 89. Zealand Pharma Revenue in Short Bowel Syndrome (SBS) Business (2018-2023) & (US$ Million)
Table 90. Zealand Pharma Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Short Bowel Syndrome (SBS) Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Short Bowel Syndrome (SBS) Market Share by Type: 2022 VS 2033
Figure 3. Oral Route Features
Figure 4. Parental Route Features
Figure 5. Global Short Bowel Syndrome (SBS) Market Size Comparison by Sale Channel (2023-2033) & (US$ Million)
Figure 6. Global Short Bowel Syndrome (SBS) Market Share by Sale Channel: 2022 VS 2033
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Short Bowel Syndrome (SBS) Report Years Considered
Figure 11. Global Short Bowel Syndrome (SBS) Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Short Bowel Syndrome (SBS) Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Short Bowel Syndrome (SBS) Market Share by Region: 2022 VS 2033
Figure 14. Global Short Bowel Syndrome (SBS) Market Share by Players in 2022
Figure 15. Global Top Short Bowel Syndrome (SBS) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Short Bowel Syndrome (SBS) as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Short Bowel Syndrome (SBS) Revenue in 2022
Figure 17. North America Short Bowel Syndrome (SBS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Short Bowel Syndrome (SBS) Market Share by Country (2018-2033)
Figure 19. United States Short Bowel Syndrome (SBS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Short Bowel Syndrome (SBS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Short Bowel Syndrome (SBS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Short Bowel Syndrome (SBS) Market Share by Country (2018-2033)
Figure 23. Germany Short Bowel Syndrome (SBS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Short Bowel Syndrome (SBS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Short Bowel Syndrome (SBS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Short Bowel Syndrome (SBS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Short Bowel Syndrome (SBS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Short Bowel Syndrome (SBS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Short Bowel Syndrome (SBS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Short Bowel Syndrome (SBS) Market Share by Region (2018-2033)
Figure 31. China Short Bowel Syndrome (SBS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Short Bowel Syndrome (SBS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Short Bowel Syndrome (SBS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Short Bowel Syndrome (SBS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Short Bowel Syndrome (SBS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Short Bowel Syndrome (SBS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Short Bowel Syndrome (SBS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Short Bowel Syndrome (SBS) Market Share by Country (2018-2033)
Figure 39. Mexico Short Bowel Syndrome (SBS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Short Bowel Syndrome (SBS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Short Bowel Syndrome (SBS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Short Bowel Syndrome (SBS) Market Share by Country (2018-2033)
Figure 43. Turkey Short Bowel Syndrome (SBS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Short Bowel Syndrome (SBS) Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Merck Revenue Growth Rate in Short Bowel Syndrome (SBS) Business (2018-2023)
Figure 46. Takeda Revenue Growth Rate in Short Bowel Syndrome (SBS) Business (2018-2023)
Figure 47. Emmaus Medical Revenue Growth Rate in Short Bowel Syndrome (SBS) Business (2018-2023)
Figure 48. Ardelyx Revenue Growth Rate in Short Bowel Syndrome (SBS) Business (2018-2023)
Figure 49. Naia Pharmaceuticals Revenue Growth Rate in Short Bowel Syndrome (SBS) Business (2018-2023)
Figure 50. Nutrinia Revenue Growth Rate in Short Bowel Syndrome (SBS) Business (2018-2023)
Figure 51. OxThera Revenue Growth Rate in Short Bowel Syndrome (SBS) Business (2018-2023)
Figure 52. Sancilio Pharmaceuticals Revenue Growth Rate in Short Bowel Syndrome (SBS) Business (2018-2023)
Figure 53. Zealand Pharma Revenue Growth Rate in Short Bowel Syndrome (SBS) Business (2018-2023)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries